Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan efficacy in persistent atrial fibrillation treated with radiofrequency ablation using CARTO-MERGE
2007-001449-16Phase 4Active
- Sponsor
- Andrés Ignacio Bodegas Cañas
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of irbesartan in Atrial fibrillation (AFib) (2 arms), sponsored by Andrés Ignacio Bodegas Cañas. Primary endpoints: Cumulative number of atrial fibrillation episodes during follow-up, Number and duration of atrial fibrillation episodes and 4 more. Started Mar 2010; status: active.
02
Drugs
irbesartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2007-001449-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001449-16.